The most frequent definitive diagnosis was MS, with 24 (63%) cases, followed by NMOSD, with 12 (32%); all patients with NMOSD tested positive for aquaporin-4 antibodies using the CBA method, and MOGAD with 2 (5%). Here, AQP4 is linked to myeloid sarcoma.